Emgality® ▼ (galcanezumab)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Emgality Summary of Product Characteristics (SmPC)

Emgality®▼ (galcanezumab): Expiration Date

The medicine should not be used after the expiry date which is stated on the label and on the carton after “EXP".

Additional Information

The expiry date refers to the last day of that month. 1

Lilly can only guarantee that the medicine is still safe and effective up to the expiration date.2 The product expires on the last day of the month reflected in the expiration date month and year format printed on the label and packaging (e.g.,”3-2021” means the medicine expires on March 31, 2021).2

References

1. Emgality [package leaflet]. Eli Lilly Nederland B.V., The Netherlands.

2. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Date of Last Review: February 15, 2019

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Ask us a question Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question